Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates…
Biotechnology
US, Marlborough [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Phio Pharmaceuticals Corp. has no acquisition track records yet.
M&A Deals · History
Phio Pharmaceuticals Corp. has no acquisition track records yet.